D. Butcher

1.4k total citations
9 papers, 815 citations indexed

About

D. Butcher is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, D. Butcher has authored 9 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Emergency Medicine. Recurrent topics in D. Butcher's work include HIV/AIDS drug development and treatment (5 papers), HIV/AIDS Research and Interventions (4 papers) and HIV Research and Treatment (3 papers). D. Butcher is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), HIV/AIDS Research and Interventions (4 papers) and HIV Research and Treatment (3 papers). D. Butcher collaborates with scholars based in United States, Germany and France. D. Butcher's co-authors include W. Gabriel, Reinhard Bürger, Michael Lynch, Karin L. Klingman, John W. Mellors, Kevin W. Garren, Richard Haubrich, Diane V. Havlir, James F. Rooney and Sharon A. Riddler and has published in prestigious journals such as Genetics, AIDS and Journal of Heredity.

In The Last Decade

D. Butcher

9 papers receiving 791 citations

Peers

D. Butcher

GENET

ID

VIROL

MB

EM

Samuel Bailin United States

J. Claiborne Stephens United States

Mary Beth Hanley United States

Megan M. Morris United States

Ana Goios Portugal

Alison F. Feder United States

Robert M. Lloyd United States

Kirston Barton Australia

Emi Shudo United States

Philip Rieder Switzerland

Samuel Bailin United States

D. Butcher

259 ×0.6

GENET

82 ×0.4

ID

46 ×0.2

VIROL

186 ×1.1

MB

125 ×0.8

EM

Citations per year, relative to D. Butcher D. Butcher (= 1×) peers Samuel Bailin

Countries citing papers authored by D. Butcher

Since Specialization

Citations

This map shows the geographic impact of D. Butcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Butcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Butcher more than expected).

Fields of papers citing papers by D. Butcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Butcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Butcher. The network helps show where D. Butcher may publish in the future.

Co-authorship network of co-authors of D. Butcher

This figure shows the co-authorship network connecting the top 25 collaborators of D. Butcher. A scholar is included among the top collaborators of D. Butcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Butcher. D. Butcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

McDonald, Cheryl, Jonathan Uy, Wenhua Hu, et al.. (2012). Clinical Significance of Hyperbilirubinemia Among HIV-1–Infected Patients Treated with Atazanavir/Ritonavir Through 96 Weeks in the CASTLE Study. AIDS Patient Care and STDs. 26(5). 259–264. 25 indexed citations

2.

Haubrich, Richard, Sharon A. Riddler, Karin L. Klingman, et al.. (2011). Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection. AIDS. 25(18). 2269–2278. 19 indexed citations

3.

Uy, J., et al.. (2010). Clinical significance of hyperbilirubinemia in the CASTLE study. Journal of the International AIDS Society. 13(S4). 3 indexed citations

4.

Jansen, Klaus, Anders Sönnerborg, P. Puglièse, et al.. (2010). Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced HIV patients. Journal of the International AIDS Society. 13. P31–P31. 1 indexed citations

5.

Jayaweera, Dushyantha, et al.. (2009). Virologic Suppression, Treatment Adherence, and Improved Quality of Life on a Once-Daily Efavirenz-Based Regimen in Treatment-Naïve HIV-1–Infected Patients Over 96 Weeks. HIV Clinical Trials. 10(6). 375–384. 18 indexed citations

6.

Haubrich, Richard, Sharon A. Riddler, A. Gregory DiRienzo, et al.. (2009). Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. 23(9). 1109–1118. 210 indexed citations

7.

Butcher, D.. (1995). Muller's ratchet, epistasis and mutation effects.. Genetics. 141(1). 431–437. 91 indexed citations

8.

Lynch, Michael, Reinhard Bürger, D. Butcher, & W. Gabriel. (1993). The Mutational Meltdown in Asexual Populations. Journal of Heredity. 84(5). 339–344. 437 indexed citations

9.

Sugishita, Y, K Iida, M. F. OʼRourke, et al.. (1990). Echocardiographic and electrocardiographic study of the normal kangaroo heart. Australian and New Zealand Journal of Medicine. 20(2). 160–165. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact